tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ashwani Verma, 92 are a BUY (68.66%), 39 are a HOLD (29.1%), 3 are a SELL (2.24%).
Analyst Ashwani Verma, currently employed at UBS, carries an average stock price target met ratio of 57.83% that have a potential upside of 27% achieved within 164 days.
Ashwani Verma’s has documented 270 price targets and ratings displayed on 24 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HRMY, Harmony Biosciences Holdings at 11-Feb-2026.
Analyst best performing recommendations are on BIIB (BIOGEN).
The best stock recommendation documented was for BIIB (BIOGEN) at 7/14/2025. The price target of $130 was fulfilled within 1 day with a profit of $3.11 (2.34%) receiving and performance score of 23.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Feb-2025
$132
$0.13 (0.10%)
$132
11 months 26 days ago
(28-Feb-2025)
12/14 (85.71%)
$3.8 (2.96%)
738
Hold Since 24-Feb-2025
$132
$0.13 (0.10%)
$100
11 months 30 days ago
(24-Feb-2025)
11/12 (91.67%)
$3.43 (2.67%)
269
Hold Since 13-Jan-2025
$100
1 years 2 days ago
(21-Feb-2025)
21/22 (95.45%)
$-27.19 (-21.38%)
170
Hold Since 25-Jun-2024
$132
$0.13 (0.10%)
$87
1 years 18 days ago
(05-Feb-2025)
8/9 (88.89%)
$4.97 (3.91%)
221
Buy Since 26-Feb-2018
$132
$0.13 (0.10%)
$89
1 years 27 days ago
(27-Jan-2025)
11/12 (91.67%)
$4.79 (3.77%)
39
Which stock is Ashwani Verma is most bullish on?
Which stock is Ashwani Verma is most reserved on?
What Year was the first public recommendation made by Ashwani Verma?
